Gastroenteritis News and Research

RSS
Gastroenteritis (also known as gastro, gastric flu, and stomach flu) refers to inflammation of the gastrointestinal tract, involving both the stomach and the small intestine and resulting in acute diarrhea. The inflammation is caused most often by infection with certain viruses, less often by bacteria or their toxins, parasites, or adverse reaction to something in the diet or medication.

Further Reading

The Native Antigen Company Expands Range of Norovirus-Like Particles

The Native Antigen Company Expands Range of Norovirus-Like Particles

The zoonotic potential of epidemic porcine deltacoronavirus

The zoonotic potential of epidemic porcine deltacoronavirus

Rising temperatures lead to increased prevalence of Vibrio bacteria in UK waters

Rising temperatures lead to increased prevalence of Vibrio bacteria in UK waters

Are our bowel habits written in our DNA?

Are our bowel habits written in our DNA?

Cheap and accessible methods for genome sequencing will help tackle future pandemics

Cheap and accessible methods for genome sequencing will help tackle future pandemics

Structure of human-infecting canine coronavirus HuPn-2018 spike glycoprotein

Structure of human-infecting canine coronavirus HuPn-2018 spike glycoprotein

Study findings may lead to new treatments to fight deadly C. difficile infections

Study findings may lead to new treatments to fight deadly C. difficile infections

Researchers plan review of cruise ship COVID-19 outbreaks

Researchers plan review of cruise ship COVID-19 outbreaks

UK Sepsis Trust calls for people to better understand the signs and symptoms of sepsis

UK Sepsis Trust calls for people to better understand the signs and symptoms of sepsis

Diagnosis of viral infections using micro and nanoscale technologies

Diagnosis of viral infections using micro and nanoscale technologies

Human coronaviruses need organic materials to transfer efficiently between surfaces

Human coronaviruses need organic materials to transfer efficiently between surfaces

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants

Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants

SARS-CoV N protein elicits production of IFN-β by provoking ubiquitination of RIG-I, finds study

SARS-CoV N protein elicits production of IFN-β by provoking ubiquitination of RIG-I, finds study

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

Study paves the way for development of new therapeutics for C. difficile infection

Study paves the way for development of new therapeutics for C. difficile infection

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

Redhill Biopharma announces completion of enrollment for oral opaganib phase 2/3 COVID-19 study

Weight loss drug Wegovy approved by FDA

Weight loss drug Wegovy approved by FDA

Salmonella bacteria colonize the gut using intestinal epithelial cells

Salmonella bacteria colonize the gut using intestinal epithelial cells